As of January 2026 Halozyme Therapeutics has a market cap of A$12.70 Billion. This makes Halozyme Therapeutics the world's 2222th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Jan 12th, 2026 the market cap of Halozyme Therapeutics was reported to be: